Kiora Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Kiora Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Kiora Pharmaceuticals Inc
Rating: 1.57183325
Author: Trendlyne DVM scores

about

Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, ...

2.09 -0.06 (-2.79%)

50.00% Fall from 52W High

19,964.4

XNAS Volume

XNAS 13 Mar, 2026 4:01 PM (EDT)

Not Eligible

Mid Valuation

31.8 / 100

Technically Bearish

31.0 / 100

1Yr Price target upside is 474%

1 analysts

Kiora Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Kiora Pharma Inc Live Stock Price Today, Share Analysis and Chart

Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, ...

50.00% Fall from 52W High

SWOT Analysis

Kiora Pharma Inc Live Price Chart